Showing results (121-130 of 277) with videos related to
Sort By:
Pageof 28
Annals of the New York Academy of Sciences|November 16, 2006
Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damageDonald M Kuhn, Dina M Francescutti-Verbeem, David M ThomasInternational Journal of Oncology|February 20, 2015
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivoJohana M Susanto, Emily K Colvin, Mark Pinese, et al.Breast Cancer Research : BCR|September 10, 2014
Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathwaysNaveid A Ali, Jianmin Wu, Falko Hochgräfe, et al.Pharmacogenomics|September 13, 2013
Multiomics medicine in oncology: assessing effectiveness, cost-effectiveness and future research priorities for the molecularly unique individualBrett Doble, Anthony Harris, David M Thomas, et al.Nature Reviews. Cancer|October 17, 2014
Translational biology of osteosarcomaMaya Kansara, Michele W Teng, Mark J Smyth, et al.Cancer Biology & Therapy|May 17, 2003
Role of the retinoblastoma protein in differentiation and senescenceDavid M Thomas, Hai-Su Yang, Kamilah Alexander, et al.The Lancet. Oncology|August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic studyMandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.Sarcoma|January 4, 2011
Targeting the p53 Pathway in Ewing SarcomaPaul M Neilsen, Kathleen I Pishas, David F Callen, et al.Medical Science Educator|August 7, 2023
A Qualitative Analysis on the Effectiveness of Peer Feedback in Team-Based LearningSarah Lerchenfeldt, Suzan Kamel-ElSayed, Gustavo Patino, et al.International Journal of Clinical Oncology|June 11, 2026
BRAF-targeted therapy in non-melanomatous BRAF-mutant tumours: a systematic review of broad but histology-modulated efficacyYael R Lefkovits, Luke S McLean, Mark R Middleton, et al.Pageof 28